Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia

JAMA Intern Med. 2021 Jan 1;181(1):12-15. doi: 10.1001/jamainternmed.2020.6557.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19*
  • Critical Illness
  • Humans
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab